Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Medical Genetics
Published in: BMC Medical Genetics 1/2010

Open Access 01-12-2010 | Research article

Novel deletion alleles carrying CYP21A1P/A2chimeric genes in Brazilian patients with 21-hydroxylase deficiency

Authors: Fernanda B Coeli, Fernanda C Soardi, Renan D Bernardi, Marcela de Araújo, Luciana C Paulino, Ivy F Lau, Reginaldo J Petroli, Sofia HV de Lemos-Marini, Maria TM Baptista, Gil Guerra-Júnior, Maricilda P de-Mello

Published in: BMC Medical Genetics | Issue 1/2010

Login to get access

Abstract

Background

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is caused by deletions, large gene conversions or mutations in CYP21A2 gene. The human gene is located at 6p21.3 within a locus containing the genes for putative serine/threonine Kinase RP, complement C4, steroid 21-hydroxylase CYP21 tenascin TNX, normally, in a duplicated cluster known as RCCX module. The CYP21 extra copy is a pseudogene (CYP21A1P). In Brazil, 30-kb deletion forming monomodular alleles that carry chimeric CYP21A1P/A2 genes corresponds to ~9% of disease-causing alleles. Such alleles are considered to result from unequal crossovers within the bimodular C4/CYP21 locus. Depending on the localization of recombination breakpoint, different alleles can be generated conferring the locus high degree of allelic variability. The purpose of the study was to investigate the variability of deleted alleles in patients with 21-hydroxylase deficiency.

Methods

We used different techniques to investigate the variability of 30-kb deletion alleles in patients with 21-hydroxylase deficiency. Alleles were first selected after Southern blotting. The composition of CYP21A1P/A2 chimeric genes was investigated by ASO-PCR and MLPA analyses followed by sequencing to refine the location of recombination breakpoints. Twenty patients carrying at least one allele with C4/CYP21 30-kb deletion were included in the study.

Results

An allele carrying a CYP21A1P/A2 chimeric gene was found unusually associated to a C4B/C4A Taq I 6.4-kb fragment, generally associated to C4B and CYP21A1P deletions. A novel haplotype bearing both p.P34L and p.H62L, novel and rare mutations, respectively, was identified in exon 1, however p.P30L, the most frequent pseudogene-derived mutation in this exon, was absent. Four unrelated patients showed this haplotype. Absence of p.P34L in CYP21A1P of normal controls indicated that it is not derived from pseudogene. In addition, the combination of different approaches revealed nine haplotypes for deleted 21-hydroxylase deficiency alleles.

Conclusions

This study demonstrated high allelic variability for 30-kb deletion in patients with 21-hydroxylase deficiency indicating that a founder effect might be improbable for most monomodular alleles carrying CYP21A1P/A2 chimeric genes in Brazil.
Appendix
Available only for authorised users
Literature
1.
New MI: Inborn errors of adrenal steroidogenesis. Mol Cel Endocrinol. 2003, 211: 75-83. 10.1016/j.mce.2003.09.013.CrossRef
2.
White PC, Speiser PW: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine Reviews. 2000, 21: 245-291. 10.1210/er.21.3.245.PubMed
3.
Keegan CE, Killeen AA: An overview of molecular diagnostic of steroid 21-hydroxylase deficiency. J Mol Diagnostic. 2001, 3: 49-54.CrossRef
4.
Carroll MC, Campbell RD, Bentley DR, Porter RR: A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature. 1984, 307: 237-241. 10.1038/307237a0.CrossRefPubMed
5.
White PC, Grossberger D, Onufer BJ, Chaplin DD, New MI, Dupont B, Strominger JL: Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth complement in man. Proc Natl Acad Sci USA. 1985, 82: 1089-1093. 10.1073/pnas.82.4.1089.CrossRefPubMedPubMedCentral
6.
Higashi Y, Yoshioka H, Yamane M, Gotoh O, Fujii-Kuriyama Y: Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc Natl Acad Sci USA. 1986, 83: 2841-2845. 10.1073/pnas.83.9.2841.CrossRefPubMedPubMedCentral
7.
8.
Yang Z, Mendoza AR, Welch TR, Zipf WB, Yu CY: Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module). A mechanism for gene deletions and disease associations. J Biol Chem. 1999, 274: 12147-12156. 10.1074/jbc.274.17.12147.CrossRefPubMed
9.
Dangel AW, Mendoza AR, Baker BJ, Daniel CM, Carroll MC, Wu LC, Yu CY: The dichotomous size variation of human complement C4 genes is mediated by a novel family of endogenous retroviruses, which also establishes species-specific genomic patterns among Old World primates. Immunogenetics. 1994, 40: 425-436. 10.1007/BF00177825.CrossRefPubMed
10.
Tassabehji M, Strachan T, Anderson M, Campbell RD, Collier S, Lako M: Identification of a novel family of human endogenous retroviruses and characterization of one family member, HERV-K(C4), located in the complement C4 gene cluster. Nucleic Acids Res. 1994, 22: 5211-5217. 10.1093/nar/22.24.5211.CrossRefPubMedPubMedCentral
11.
Chu X, Rittner C, Schneider PM: Length polymorphism of the human complement component C4 gene is due to an ancient retroviral integration. Exp Clin Immunogenet. 1995, 12: 74-81.PubMed
12.
Blanchong CA, Zhou B, Rupert KL, Chung EK, Jones KN, Sotos JF, Zipf WB, Rennebohm RM, Yu Yung C: Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med. 2000, 191: 2183-2196. 10.1084/jem.191.12.2183.CrossRefPubMedPubMedCentral
13.
Schneider PM, Carroll MC, Alper CA, Rittner C, Whitehead AS, Yunis EJ, Colten HR: Polymorphism of the human complement C4 and steroid 21-hydroxylase genes. Restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants. J Clin Invest. 1986, 78: 650-657. 10.1172/JCI112623.CrossRefPubMedPubMedCentral
14.
Koppens PF, Hoogenboezem T, Degenhart HJ: Duplication of the CYP21A2 gene complicates mutation analysis of steroid 21-hydroxylase deficiency: characteristics of three unusual haplotypes. Hum Genet. 2002, 111: 405-10. 10.1007/s00439-002-0810-7.CrossRefPubMed
15.
Lee HH: Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module. Mol Gen Met. 2005, 84: 4-8. 10.1016/j.ymgme.2004.09.009.CrossRef
16.
Carroll MC, Palsdottir A, Belt KT, Porter RR: Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region. EMBO J. 1985, 4: 2547-2552.PubMedPubMedCentral
17.
Werkmeister JW, New MI, Dupont B, White PC: Frequent deletion and duplication of the steroid 21-hydroxylase genes. Am J Hum Genet. 1986, 39: 461-469.PubMedPubMedCentral
18.
White PC, Vilek A, Dupont B, New MI: Characterization of frequent deletions causing steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA. 1988, 85: 4436-4440. 10.1073/pnas.85.12.4436.CrossRefPubMedPubMedCentral
19.
Morel Y, David M, Forest MG, Betuel H, Hauptman G, Andre J, Bertrand J, Miller WL: Gene conversions and rearrangements cause discordance between inheritance of forms of 21-hydroxylase deficiency and HLA types. J Clin Endocrinol Metab. 1989, 68: 592-599. 10.1210/jcem-68-3-592.CrossRefPubMed
20.
Donohoue PA, Jospe N, Migeon CJ, Van Dop C: Two distinct areas of unequal crossingover within the steroid 21-hydroxylase genes produce absence of CYP21B. Genomics. 1989, 5: 397-406. 10.1016/0888-7543(89)90002-5.CrossRefPubMed
21.
Lee HH: Diversity of the CYP21P-like gene in CYP21 deficiency. DNA Cell Biol. 2005, 24: 1-9. 10.1089/dna.2005.24.1.CrossRefPubMed
22.
Paldosttir A, Fossdal R, Arnason A, Edwards JH, Jennson O: Heterogeneity of human C4 gene size, a large intron (6.6 kb) is present in all C4A genes and some C4B genes. Immunogenetics. 1987, 25: 299-304. 10.1007/BF00404422.CrossRef
23.
Haglund-Stengler B, Martin Ritzén E, Gustafsson J, Luthman H: Haplotypes of the steroid 21-hydroxylase gene region encoding mild steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA. 1991, 88: 8352-8356. 10.1073/pnas.88.19.8352.CrossRefPubMedPubMedCentral
24.
Torresani T, Biason-Lauber A: Congenital adrenal hyperplasia: diagnostic advances. J Inherit Metab Dis. 2007, 30: 563-575. 10.1007/s10545-007-0696-6.CrossRefPubMed
25.
Lee HH, Chang JG, Tsai CH, Tsai FJ, Chao HT, Chung B: Analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency. Clin Chem. 2000, 46: 606-611.PubMed
26.
Lee HH, Niu DM, Lin RW, Chan P, Lin CY: Structural analysis of the chimeric CYP21P/CYP21 gene in steroid 21-hydroxylase deficiency. J Hum Genet. 2002, 47: 517-522. 10.1007/s100380200077.CrossRefPubMed
27.
Friães A, Rêgo AT, Aragüés JM, Moura LF, Mirante A, Mascarenhas MR, Kay TT, Lopes LA, Rodrigues JC, Guerra S, Dias T, Teles AG, Gonçalves J: CYP21A2 mutations in Portuguese patients with congenital adrenal hyperplasia: identification of two novel mutations and characterization of four different partial gene conversions. Mol Genet Metab. 2006, 88: 58-65. 10.1016/j.ymgme.2005.11.015.CrossRefPubMed
28.
Concolino P, Mello E, Minucci A, Giardina E, Zuppi C, Toscano V, Capoluongo E: A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form. BMC Med Genet. 2009, 22: 10-72.
29.
De Araujo M, Sanches MR, Suzuki LA, Guerra G, Farah SB, De Mello MP: Molecular Analysis of CYP21 and C4 Genes in Brazilian Families the Classical Congenital Adrenal Hyperplasia. Brazilian J Med Biol Res. 1996, 29: 1-13.
30.
Bachega TA, Billerbeck AE, Madureira G, Arnhold IJ, Medeiros MA, Marcondes JA, Longui CA, Nicolau W, Bloise W, Mendonca BB: Low frequency of CYP2B deletions in Brazilian patients with congenital adrenal hyperplasia due to 21-hydroxylas deficiency. Hum Hered. 1999, 49: 9-14. 10.1159/000022833.CrossRefPubMed
31.
Sambrook J, Fritsch EF, Maniatis TE: Molecular cloning, a laboratory manual. 1989, New York: Cold Spring Harbor
32.
Wilson RC, Wei JQ, Cheng KC, Mercado AB, New MI: Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain raction for detection of mutations in the 21-hydroxylase gene. J Clin Endocrinol Metab. 1995, 80: 1635-1640. 10.1210/jc.80.5.1635.PubMed
33.
34.
Taylor CF, Charlton RS, Burn J, Sheridan E, Taylor GR: Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA. Hum Mutat. 2003, 22: 428-433. 10.1002/humu.10291.CrossRefPubMed
35.
Parajes S, Quinterio C, Domínguez F, Loidi L: A simple and robust quantitative PCR assay to determine CYP21A2 gene dose in the diagnosis of 21-hydroxylase deficiency. Clin Chem. 2007, 53: 1577-84. 10.1373/clinchem.2007.087361.CrossRefPubMed
36.
Szilagyi A, Blasko B, Szilassy D, Fust G, Sasvari-Szekely M, Ronai Z: Real-time PCR quantification of human complement C4A and C4B genes. BMC Genet. 2006, 10: 1-10.1186/1471-2156-7-1.CrossRef
37.
Kleinle S, Lang R, Fischer GF, Vierhapper H, Waldhauser F, Födinger M, Baumgartner-Parzer SM: Duplications of the functional CYP21A2 gene are primarily restricted to Q318X alleles: evidence for a founder effect. J Clin Endocrinol Metab. 2009, 94: 3954-8. 10.1210/jc.2009-0487.CrossRefPubMed
38.
Koppens PF, Hoogenboezem T, Degenhart HJ: A rare TaqI polymorphism in a human complement C4 gene is caused by an additional restriction site in the first intron. Immunol Lett. 1992, 34: 93-97. 10.1016/0165-2478(92)90233-E.CrossRefPubMed
39.
Kharrat M, Tardy V, M'Rad R, Maazoul F, Jemaa LB, Refaï M, Morel Y, Chaabouni H: Molecular genetic analysis of Tunisian patients with a classic form of 21-hydroxylase deficiency: identification of four novel mutations and high prevalence of Q318X mutation. J Clin Endocrinol Metab. 2004, 89: 368-74. 10.1210/jc.2003-031056.CrossRefPubMed
40.
Koppens PF, Hoogenboezem T, Degenhart HJ: CYP21 and CYP21P variability in steroid 21-hydroxylase deficiency patients and in the general population in the Netherlands. Eur J Hum Genet. 2000, 8: 827-836. 10.1038/sj.ejhg.5200543.CrossRefPubMed
41.
Sinnott P, Collier S, Costigan C, Dyer PA, Harris R, Strachan T: Genesis by meiotic unequal crossover of a de novo deletion that contributes to steroid 21-hydroxylase deficiency. Proc Natl Acad Sci USA. 1990, 87: 2107-2111. 10.1073/pnas.87.6.2107.CrossRefPubMedPubMedCentral
42.
Guerra-Junior G, Grumach AS, Lemos-Marini SH, Kirschfink M, Condino Neto A, de Araujo M, De Mello MP: Complement 4 phenotypes and genotypes in Brazilian patients with classical 21-hydroxylase deficiency. Clin Exp Immunol. 2009, 155: 182-188. 10.1111/j.1365-2249.2008.03838.x.CrossRefPubMedPubMedCentral
43.
Dodds AW, Ren XD, Willis AC, Law SK: The reaction mechanism of the internal thioester in the human complement component C4. Nature. 1996, 379: 177-179. 10.1038/379177a0.CrossRefPubMed
44.
Donohoue PA, Guethlein L, Collins MM, Van Dop C, Migeon CJ, Bias WB, Schmeckpeper BJ: The HLA-A3, Cw6,B47,DR7 extended haplotypes in salt losing 21-hydroxylase deficiency and in the Old Order Amish: identical class I antigens and class II alleles with at least two crossover sites in the class III region. Tissue Antigens. 1995, 46: 163-172. 10.1111/j.1399-0039.1995.tb03115.x.CrossRefPubMed
45.
Chung EK, Yang Y, Rennebohm RM, Lokki ML, Higgins GC, Jones KN, Zhou B, Blanchong CA, Yu CY: Genetic sophistication of human complement components C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex. Am J Hum Genet. 2002, 71: 823-837. 10.1086/342777.CrossRefPubMedPubMedCentral
46.
Chu X, Braun-Heimer L, Rittner C, Schneider PM: Identification of the recombination site within the steroid 21-hydroxylase gene (CYP21) of the HLA B47,DR7 haplotype. Exp Clin Immunogenet. 1992, 9: 80-85.PubMed
47.
L'Allemand D, Tardy V, Grüters A, Schnabel D, Krude H, Morel Y: How a patient homozygous for a 30-kb deletion of the C4-CYP 21 genomic region can have a nonclassic form of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2000, 85: 4562-4567. 10.1210/jc.85.12.4562.CrossRefPubMed
48.
Fasano MB, Winkelstein JA, LaRosa T, Bias WB, McLean RH: A unique recombination event resulting in a C4A*Q0,C4B*Q0 double null haplotype. J Clin Invest. 1992, 90: 1180-1184. 10.1172/JCI115978.CrossRefPubMedPubMedCentral
49.
Koppens P, Smeets H, de Wijs IJ, Degenhart H: Mapping of a de novo unequal crossover causing a deletion of the steroid 21-hydroxylase (CYP21A2) gene and a non-functional hybrid tenascin-X (TNXB) gene. J Med Genet. 2003, 40: e53-10.1136/jmg.40.5.e53.CrossRefPubMedPubMedCentral
50.
Soardi FC, Barbaro M, Lau IF, Lemos-Marini SH, Baptista MT, Guerra-Junior G, Wedell A, Lajic S, de Mello MP: Inhibition of CYP21A2 enzyme activity caused by novel missense mutations identified in Brazilian and Scandinavian patients. J Clin Endocrinol Metab. 2008, 93: 2416-2420. 10.1210/jc.2007-2594.CrossRefPubMed
51.
Menassa R, Tardy V, Despert F, Bouvattier-Morel C, Brossier JP, Cartigny M, Morel Y: p.H62L, a rare mutation of the CYP21 gene identified in two forms of 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2008, 93: 1901-1908. 10.1210/jc.2007-2701.CrossRefPubMed
52.
Figueiredo MS, Kerbauy J, Goncalves MS, Arruda VR, Saad ST, Sonati MF, Stoming T, Costa FF: Effect of ?-Thalassemia and ?s-Globin Gene Cluster Haplotypes on the Hematological and Clinical Features of Sickle Anemia in Brazil. Am J Hematol. 1996, 53: 72-76. 10.1002/(SICI)1096-8652(199610)53:2<72::AID-AJH3>3.0.CO;2-0.CrossRefPubMed
53.
Killeen AA, Sane KS, Orr HT: Molecular and endocrine characterization of a mutation involving a recombination between the steroid 21-hydroxylase functional gene and pseudogene. J Steroid Biochem Mol Biol. 1991, 38: 677-686. 10.1016/0960-0760(91)90078-J.CrossRefPubMed
54.
Kyllo JH, Collins MM, Donohoue PA: Constitutive human steroid 21-hydroxylase promoter gene and pseudogene activity in steroidogenic and nonsteroidogenic cells with the luciferase gene as a reporter. Endocr Res. 1995, 21: 777-91.CrossRefPubMed
55.
Sørensen KM, Andersen PS, Larsen LA, Schwartz M, Schouten JP, Nygren AO: Multiplex Ligation-Dependent Probe Amplification Technique for Copy Number Analysis on Small Amounts of DNA Material. Anal Chem. 2008, 80: 9363-9368. 10.1021/ac801688c.CrossRefPubMed
Metadata
Title
Novel deletion alleles carrying CYP21A1P/A2chimeric genes in Brazilian patients with 21-hydroxylase deficiency
Authors
Fernanda B Coeli
Fernanda C Soardi
Renan D Bernardi
Marcela de Araújo
Luciana C Paulino
Ivy F Lau
Reginaldo J Petroli
Sofia HV de Lemos-Marini
Maria TM Baptista
Gil Guerra-Júnior
Maricilda P de-Mello
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Medical Genetics / Issue 1/2010
Electronic ISSN: 1471-2350
DOI
https://doi.org/10.1186/1471-2350-11-104

Other articles of this Issue 1/2010

BMC Medical Genetics 1/2010 Go to the issue

Research article

Variant rs9939609 in the FTO gene is associated with body mass index among Chinese children

Research article

Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemia

Research article

Obesity and diabetes genes are associated with being born small for gestational age: Results from the Auckland Birthweight Collaborative study

Case report

A de novo marker chromosome derived from 9p in a patient with 9p partial duplication syndrome and autism features: genotype-phenotype correlation

Research article

A case-control analysis of common variants in GIP with type 2 diabetes and related biochemical parameters in a South Indian population

Research article

EEG alpha phenotypes: linkage analyses and relation to alcohol dependence in an American Indian community study